ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > Kits > IFN-gamma > CEA-C006

ClinMax™ Human IFN-γ ELISA Kit, PRO

For research use only.
    Product Details
    ClinMax™ Human IFN-γ ELISA Kit, PRO is a ready-to-use immunoassay kit, specifically designed to quantitate natural and recombinant human IFN-gamma that is present in biological samples, such as human serum, plasma, and cell culture supernatants. Our ClinMax™ ELISA Kit provides several benefits:
    1. Standards to calibrate with NIBSC/WHO standards for comparable results.
    2. Fully validation in biologic samples for detection range, sensitivity, inter- and intra-plate CV, recovery, dilution linearity, specificity, and matrix effects to ensure reliable results according to ICH M10 guideline.
    3. High-quality antibody pairs and protein standards, along with rigorous quality control, to guarantee consistent results across different batches.
    4. Simplified and straightforward protocols and ready-to-use reagents to save assay time.
  • Application

    The kit is developed for quantitative detection of natural and recombinant human IFN-gamma in serum, plasma and cell culture supernatants.

    It is suitable for potency assay of CAR-T/NK cell therapy. It has been calibrated against a highly purified human IFN-γ and is evaluated with standard from NIBSC/WHO. Reference Reagent INTERFERON GAMMA (Human, rDNA derived) NIBSC code: 82/587.

    It is for research use only.

  • Workflow
     IFN-gamma Workflow
    Key Features
    AnalyteIFN-γ
    Assay TypeSandwich-ELISA
    ReactivityHuman
    Sensitivity4pg/mL
    Range7.81 pg/mL-1000 pg/mL
    Assay Time2 hr
    Sample TypeCell Culture Supernatants, Plasma, Serum.
    Sample volume50 uL
    Format96-wells plate breakable into 12 x 8 wells strips

    Elevate your research experience with our Cytokine/Biomarker Detection Kits, where accuracy, reliability, and ease of use are converging to deliver exceptional results.

  • Storage
    Keep the unopened kit stored at 2-8 °C. Avoid using the kit beyond its expiration date. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
Typical Data Please refer to DS document for the assay protocol.
 IFN-gamma TYPICAL DATA

For each experiment, a standard curve needs to be set for each microplate, and the specific OD value may vary depending on different laboratories, testers, or equipment. The following example data is for reference only. The sample concentration was calculated based on the results of the standard curve. The minimum detectable concentration of IFN-γ is less than 4.0 pg/mL.

Validation
Sample Values

Serum - IFN-γ concentrations were measured in 208 human serum samples, which were collected from healthy human subjects. The measurements of 208 samples are shown in the figure below.

 IFN-gamma SAMPLE VALUES
Matrix Effect

3 types of materials were tested to observe if there were matrix effect (interference). If the concentration of hemoglobin (simulated hemolysis) is less than 3500 mg/dL, the concentration of triglyceride (simulated lipid blood) is less than 3.0 mg/mL, and the concentration of bilirubin (simulated jaundice) is less than 20 mg/dL, testing results will not be affected.

 IFN-gamma MATRIX EFFECT
Hook Effect

According to the hook effect evaluation, tested results will not be affected when IFN-γ concentration is higher than 250 ng/mL.

 IFN-gamma HOOK EFFECT
Dilution Linearity

High concentrations of human IFN-γ serum samples were diluted with 1:2, 1:4, 1:8, 1:16, 1:32 and 1:64 ratios for gradient dilution to evaluate the linearity of the assay. In the serum samples, the average detection rate of IFN-γ was 99.16%.

 IFN-gamma DILUTION LINEARITY
Intra-Assay Statistics

10 replicates of each of 4 samples containing different IFN-γ concentrations were tested in one assay. Acceptable criteria: CV<10%.

 IFN-gamma INTRA-ASSAY STATISTICS
Inter-Assay Statistics

4 samples containing different concentrations of IFN-γ were tested in the independent assays. Acceptable criteria: CV<15%.

 IFN-gamma INTER-ASSAY STATISTICS
Recovery

IFN-γ was spiked into 5 human serum samples, and then analyzed. The average recovery of IFN-γ for serum samples is 95.92%.

 IFN-gamma RECOVERY
Materials Provided
IDComponentsSize
CEA006-C01Pre-coated Anti-IFN-γ Antibody Microplate1 plate
CEA006-C02Human IFN-γ Standard14 μg×2
CEA006-C03Biotin-Anti-IFN-γ Antibody Con. Solution150 μL
CEA006-C04Biotin-Antibody Dilution Buffer8 mL
CEA006-C05Streptavidin-HRP Con. Solution500 μL
CEA006-C06Streptavidin-HRP Dilution Buffer15 mL
CEA006-C0720× Washing Buffer50 mL
CEA006-C08Sample Dilution Buffer15 mL×2
CEA006-C09Substrate Solution12 mL
CEA006-C10Stop Solution6 mL
  • Clinical and Translational Updates

コメント (0)


ETD of in-stock products: 4 business days

価格(JPY) : 153,720

価格(JPY) : 1,383,480

価格(JPY) : 3,689,280

プロモーション&展示



医薬品開発状況

  • Number of Launched Drugs:3 Details
  • Number of Drugs in Clinical Trials:9 Details
  • Latest Research Phase:Approved

データシート&ドキュメンテーション

DMF請求
DMF (Drug Master File)

関連製品一覧

新製品

お問い合わせ&コメント

This web search service is supported by Google Inc.

totopphone